Clinical Trials List
Protocol Number506-MA-1001
2014-03-01 - 2016-06-30
Phase IV
Terminated2
-
Trial Applicant
Astellas Pharma Inc.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 金光亮 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 劉冠麟 Division of Urology
- Ya-Chung Tian Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Completed
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
16 participants
-
Global
100 participants
